Cargando…

The global fatty liver disease Sustainable Development Goal country score for 195 countries and territories

BACKGROUND AND AIMS: Fatty liver disease is highly prevalent, resulting in overarching wellbeing and economic costs. Addressing it requires comprehensive and coordinated multisectoral action. We developed a fatty liver disease Sustainable Development Goal (SDG) country score to provide insights into...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lazarus, Jeffrey V., Han, Hannah, Mark, Henry E., Alqahtani, Saleh A., Schattenberg, Jörn M., Soriano, Joan B., White, Trenton M., Zelber-Sagi, Shira, Dirac, M. Ashworth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Original Articles: Steatohepatitis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442089/ https://www.ncbi.nlm.nih.gov/pubmed/37595128 http://dx.doi.org/10.1097/HEP.0000000000000361

Ejemplares similares

Tropifexor plus cenicriviroc combination versus monotherapy in nonalcoholic steatohepatitis: Results from the phase 2b TANDEM study
por: Anstee, Quentin M., et al.
Publicado: (2023)

Measuring human capital: a systematic analysis of 195 countries and territories, 1990–2016
por: Lim, Stephen S, et al.
Publicado: (2018)

The burden of kidney cancer and its attributable risk factors in 195 countries and territories, 1990–2017
por: Safiri, Saeid, et al.
Publicado: (2020)

Progress in adolescent health and wellbeing: tracking 12 headline indicators for 195 countries and territories, 1990–2016
por: Azzopardi, Peter S, et al.
Publicado: (2019)

Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017
Publicado: (2018)

Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025
por: Lin, Xiling, et al.
Publicado: (2020)

The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
por: Younossi, Zobair M., et al.
Publicado: (2023)

Head-to-head comparison of magnetic resonance elastography-based liver stiffness, fat fraction, and T1 relaxation time in identifying at-risk NASH
por: Li, Jiahui, et al.
Publicado: (2023)

Macrophage‐derived MLKL in alcohol‐associated liver disease: Regulation of phagocytosis
por: Wu, Xiaoqin, et al.
Publicado: (2023)

Fatty liver disease is not associated with increased mortality in the elderly: A prospective cohort study
por: van Kleef, Laurens A., et al.
Publicado: (2023)

Vertical sleeve gastrectomy activates GPBAR‐1/TGR5 to sustain weight loss, improve fatty liver, and remit insulin resistance in mice
por: Ding, Lili, et al.
Publicado: (2016)

Estimating global and regional between-country inequality in routine childhood vaccine coverage in 195 countries and territories from 2019 to 2021: a longitudinal study
por: Lai, Xiaozhen, et al.
Publicado: (2023)

A GBD 2019 study of health and Sustainable Development Goal gains and forecasts to 2030 in Spain
por: Lazarus, Jeffrey V., et al.
Publicado: (2022)

A multistakeholder approach to innovations in NAFLD care
por: Schattenberg, Jörn M., et al.
Publicado: (2023)

RIPK3 dampens mitochondrial bioenergetics and lipid droplet dynamics in metabolic liver disease
por: Afonso, Marta B., et al.
Publicado: (2023)

The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent
por: Goikoetxea-Usandizaga, Naroa, et al.
Publicado: (2023)

Apolipoprotein F is reduced in humans with steatosis and controls plasma triglyceride‐rich lipoprotein metabolism
por: Deprince, Audrey, et al.
Publicado: (2023)

Intestinal peroxisome proliferator‐activated receptor α‐fatty acid‐binding protein 1 axis modulates nonalcoholic steatohepatitis
por: Yan, Tingting, et al.
Publicado: (2023)

Relationship between NAFLD and coronary artery disease: A Mendelian randomization study
por: Ren, Zhewen, et al.
Publicado: (2023)

Myeloid p38 activation maintains macrophage–liver crosstalk and BAT thermogenesis through IL‐12–FGF21 axis
por: Crespo, María, et al.
Publicado: (2023)

Lipocalin‐2 activates hepatic stellate cells and promotes nonalcoholic steatohepatitis in high‐fat diet–fed Ob/Ob mice
por: Kim, Kyung Eun, et al.
Publicado: (2023)

Metabolic dysfunction‐associated fatty liver disease and excessive alcohol consumption are both independent risk factors for mortality
por: van Kleef, Laurens A., et al.
Publicado: (2023)

Enhanced mitochondrial activity reshapes a gut microbiota profile that delays NASH progression
por: Juárez‐Fernández, María, et al.
Publicado: (2023)

Circulating TREM2 as a noninvasive diagnostic biomarker for NASH in patients with elevated liver stiffness
por: Indira Chandran, Vineesh, et al.
Publicado: (2023)

Hepatic mitochondrial NAD(+) transporter SLC25A47 activates AMPKα mediating lipid metabolism and tumorigenesis
por: Cheng, Lili, et al.
Publicado: (2023)

Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
Publicado: (2018)

Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017
Publicado: (2018)

The global, regional, and national burden of atopic dermatitis in 195 countries and territories: An ecological study from the Global Burden of Disease Study 2017
por: Urban, Katelyn, et al.
Publicado: (2020)

Fertility, mortality, migration, and population scenarios for 195 countries and territories from 2017 to 2100: a forecasting analysis for the Global Burden of Disease Study
por: Vollset, Stein Emil, et al.
Publicado: (2020)

Innovative financing of the sustainable development goals in the countries of the Western Balkans
por: Lukšić, Igor, et al.
Publicado: (2022)

ASEAN countries’ environmental policies for the Sustainable Development Goals (SDGs)
por: Elder, Mark, et al.
Publicado: (2022)

The global burden of disease attributable to high body mass index in 195 countries and territories, 1990–2017: An analysis of the Global Burden of Disease Study
por: Dai, Haijiang, et al.
Publicado: (2020)

The global, regional, and national burden of pancreatitis in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
por: Ouyang, Guoqing, et al.
Publicado: (2020)

Loss of life expectancy due to respiratory infectious diseases: findings from the global burden of disease study in 195 countries and territories 1990–2017
por: Huang, Guogui, et al.
Publicado: (2022)

The global burden of thyroid cancer and its attributable risk factor in 195 countries and territories: A systematic analysis for the Global Burden of Disease Study
por: Zhai, Mimi, et al.
Publicado: (2021)

Global, regional, and national burden of cervical cancer for 195 countries and territories, 2007–2017: findings from the Global Burden of Disease Study 2017
por: Zhao, Miaomiao, et al.
Publicado: (2021)

Health expenditures by services and providers for 195 countries, 2000–2017
por: Schneider, Matthew T, et al.
Publicado: (2021)

Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015
Publicado: (2017)

The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
Publicado: (2020)

The effect of taxation on sustainable development goals: evidence from emerging countries
por: Rahman, Md. Mominur
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hlnap1tlscq3r57e60aefqm2ib